Evidence map›Paper›PMID 14718553›Full record

ArticleNucleic acids research2004

A novel assay to determine the sequence preference and affinity of DNA minor groove binding compounds.

Rita Thomas, Carolyn Gonzalez, Christopher Roberts, Janos Botyanszki, Lillian Lou, Emil F Michelotti

Abstract read
In one paragraph

Article in Nucleic acids research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rita ThomasGenelabs Technologies, Inc., Redwood City, CA 94063, USA.
Carolyn Gonzalez
Christopher Roberts
Janos Botyanszki
Lillian Lou
Emil F Michelotti

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sequence-specific binding in the minor groove of DNA by small molecules is a growing area of research with possible therapeutic relevance. By selectively binding to DNA sequences required by critical transcription factors, these small molecules could potentially modulate the expression levels of disease-causing genes. Precise targeting of a critical transcription factor of a selected gene requires an understanding of the preferred sequence of the DNA binding compound. As new compounds are being synthesized, there is a need to evaluate their DNA recognition profile. We sought to establish a procedure to determine sequence preference of compounds with previously unknown binding properties. A novel procedure for determining the optimal DNA binding sequence of minor groove binding compounds is described here. The assay also allows for determination of the binding affinity to a particular sequence.

Indexed as

LigandsNucleic Acid ConformationBase SequenceBinding SitesDeoxyribonuclease IDistamycinsDNADNA FootprintingDNA GlycosylasesMolecular Sequence DataOligodeoxyribonucleotidesReproducibility of ResultsSubstrate SpecificityUracil-DNA GlycosidaseDeoxyribonuclease IDistamycinsDNADNA GlycosylasesLigandsOligodeoxyribonucleotidesstallimycinUracil-DNA Glycosidase

Identifiers

PMID14718553
PMCPMC373301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.